Cargando…
Molecular insights into the inhibition mechanism of harringtonine against essential proteins associated with SARS-CoV-2 entry
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has recently posed a serious threat to global public health. Harringtonine (HT), as a small-molecule antagonist, has antiviral activity against a variety of viruses. There is evidence that HT can inhibit the SARS-CoV-2 entry into host cell...
Autores principales: | Yang, Zhiwei, Fu, Xinyue, Zhao, Yizhen, Li, Xuhua, Long, Jiangang, Zhang, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10085973/ https://www.ncbi.nlm.nih.gov/pubmed/37054859 http://dx.doi.org/10.1016/j.ijbiomac.2023.124352 |
Ejemplares similares
-
Harringtonine Inhibits Herpes Simplex Virus Type 1 Infection by Reducing Herpes Virus Entry Mediator Expression
por: Liu, Ye, et al.
Publicado: (2021) -
Harringtonine Inhibits Zika Virus Infection through Multiple Mechanisms
por: Lai, Zheng-Zong, et al.
Publicado: (2020) -
Harringtonine: A more effective antagonist for Omicron variant
por: Hu, Shiling, et al.
Publicado: (2023) -
Homo-harringtonine, highly effective against coronaviruses, is safe in treating COVID-19 by nebulization
por: Ma, Huajuan, et al.
Publicado: (2022) -
A proposal for clinical trials of COVID-19 treatment using homo-harringtonine
por: Wen, Hai-Jun, et al.
Publicado: (2020)